# Hypertension

### Medications

| Class | Indicated | Contraindicated |
| --- | --- | --- |
| __Diuretics__<br><small>__Thiazide, Thizide-like:__</small> HCT, Xipamid<br><small>__Loop Diuretics:__</small> Furosemid | Cardiac Insufficiency<br>Osteoporosis | Diabetes mellitus<br>Gicht<br>Metabolic Syndrome<br>Hypopotassemia<br>Pregnancy |
| __ACEi__<br><small>_Angiotensin Coverting Enzyme Inhibitor_</small><br>Enalapril, Ramipril | Diabetes mellitus <small>(Nephroprotective)</small><br>Cardiac Insufficiency<br>Left Ventricular Hypertrophy<br>Arteriosclerosis<br>Atrial Fibrillation<br>after Myocardial Infarct<br>Yound Age<br>Metabolic Syndrome | Renal Failure<br>Hyperpotassemia<br>Pregnancy<br>Cardiac Valvular Stenosis |
| __ARB__<br><small>_Angiotensin I Receptor Blocker_</small><br>Candesartan, Valsartan | – &middot;&middot; – | – &middot;&middot; – |
| __CCB__<br><small>_Calcium Channel Blocker_</small><br><small>__Dihydropyridine (DHP):__</small> Amlodipin<br><small>__Non-Dihydropyridine (NDHP):__</small> Verapamil, Diltiazem | Peripheral Artery Disease<br>Stable Angina<br>Metabolic Syndrome<br>Raynaud Syndrome<br>Prinzmetal Angina<br>Achalasia | Cardiac Insufficiency<br>Unstable Angina<br>Actue Myocardial Infarct<br>Bradycardic Arrhzthmia<br>GERD<br>Pregnancy |
| __Beta-Blocker__<br>Metoprolol, Bisoprolo | Coronary Heart Disease<br>after Myocardial Infarct<br>Cardiac Insufficiency<br>Tachycardic Arrhythmia<br>Pregnancy | Bradycardic Arrhythmia<br>Peripheral Artery Disease<br>Diabetes mellitus<br>Metabolic Syndrome<br>Asthma<br>Raynaud Syndrome |
| __MRA__<br><small>_Mineralocorticoid Receptor Antagonists_</small><br>Spironolacton, Eplerenon | Resistant Hypertension<br>Left Ventricular Hypertrophy | Renal Insufficiency<br>Hepatic Failure<br>Hypepotassemia<br>Pregnancy |

## Guidelines

### Basic Strategy for Uncomplicated Hypertension

| Steps | Therapy |
| ---: | --- |
| 0 | Monotherapy if systolic BP < 150 mmHg |
| 1 | <small>Dualtherapy</small><br>ACEi/ARB + CCB/Diuretic |
| 2 | <small>Trippletherapy</small><br>ACEi/ARB + CCB + Diuretic |
| 3 | Tripple Therapy<br>+<br>Spironolacton <sup>(25 – 50 mg)</sup>/Diuretic/Alpha-Blocker/Beta-Blocker |

### Hypertension and Coronary Heart Disease

| Steps | Therapy |
| ---: | --- |
| 0 | Monotherapy if systolic BP < 150 mmHg |
| 1 | ACEi/ARB __+__ Beta-Blocker/CCB<br><small>__OR__</small><br>CCB + Diuretic/Beta-Blocker<br><small>__OR__</small><br>Betablocker + Diuretica
| 2 | Tripple Therapy |
| 3 | Tripple Therapy<br>+<br>Spironolacton <sup>(25 – 50 mg)</sup>/Diuretic/Alpha-Blocker/Beta-Blocker |

### Hypertension and Chronic Kidney Disease

| Steps | Therapy |
| ---: | --- |
| 1 | ACEi/ARB + CCB<br><small>__OR__</small><br>ACEi/ARB + Diuretics/Loop Diuretics <sup>[[1]](#Notes)</sup> |
| 2 | <small>Trippletherapy</small><br>ACEi/ARB + CCB + Diuretics/Loop Diuretics <sup>[[1]](#Notes)</sup> |
| 3 | Tripple Therapie<br>+<br>Spironolacton <sup>(25 – 50 mg)</sup>/Diuretic/Alpha-Blocker/Beta-Blocker |

### Hypertension and Cardiac Insufficiency with Reduced Ejection Fraction

| Steps | Therapy |
| ---: | --- |
| Initial | ACEi/ARB + Diuretics/Loop Diuretics <sup>[[1]](#Notes)</sup> + Beta-Blocker |
| 2 | ACEi/ARB + Diuretics/Loop Diuretics <sup>[[1]](#Notes)</sup> + Beta-Blocker + MRA |

### Hypertension and Atrial Fibrillation

| Steps | Therapy |
| ---: | --- |
| Initial | ACEi/ARB + Beta-Blocker/NDHP-CCB <sup>[[2]](#Notes)</sup><br><small>__OR__</small><br>Betablocker + CCB |
| 2 | ACEi/ARB + Beta-Blocker + DHP-CCB/Diuretics<br><small>__OR__</small><br>Beta-Blocker + DHP-CCB + Diuretics |

#### Notes

1. __Loop Diuretics__ are indicated when __GFR < 30 ml/min/1.72 m<sup>2</sup>__
2. Route combination of __Beta-Blockers__ with __NDHP-CCB__ is not recommended because of potential for significant reduction in Heart Rate.